MS Medications Stay on PBS | Sydney News
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
MS Medications Stay on PBS | Sydney News
-
ナレーター：
-
著者：
Australians with multiple sclerosis can breathe easier as key life-saving drugs—Ocrevus, Kesimpta, and Lemtrada—will stay on the PBS, avoiding crippling out-of-pocket costs of up to $33,000 per prescription. Health Minister Mark Butler has launched a swift review to ensure continued access, following expert advice and a strong recommendation from the Pharmaceutical Benefits Advisory Committee. Pharmaceutical companies initially resisted price cuts, but the government’s decisive action has secured these vital treatments for now, while ongoing negotiations continue to protect patient access.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/a18863d29f1b0e34